Skip to main content

Table 2 Characteristics of fungemia and bacteremia episodes at diagnosis

From: Characteristics and risk factors for 28-day mortality of hospital acquired fungemias in ICUs: data from the EUROBACT study

Variable Bacteremia patients (n = 1,060) Fungemia patients (n = 96) P value
Delay between ICU admission and BSI, days, median (IQR) 8 (3–16) 9 (3–15.5) 0.9812
Delay between hospital admission and BSI, days, median (IQR) 13 (7–25) 20 (10.5–30.5) 0.1299
Delay to positivity of the blood culture sampling, days, median (IQR) 38.1 (21.1–69.2) 48.7 (33–81) 0.0004
Sepsis syndrome    0.5420
 Sepsis, n (%) 136 (12.8) 14 (14.6)  
 Severe sepsis, n (%) 442 (41.7) 34 (35.4)  
 Septic shock, n (%) 482 (45.5) 48 (50)  
SOFA score    0.4812
 0–4, n (%) 256 (24.2) 17 (17.7)  
 5–7, n (%) 284 (26.8) 24 (25)  
 8–11, n (%) 300 (28.3) 31 (32.3)  
 ≥12, n (%) 220 (20.8) 24 (25)  
SOFA respiratory ≥3, n (%) 499 (47.1) 45 (46.9) 0.9385
SOFA cardiovascular ≥3, n (%) 441 (41.6) 47 (49) 0.2493
SOFA neurological ≥3, n (%) 340 (32.1) 32 (33.3) 0.6578
SOFA renal ≥3, n (%) 172 (16.2) 25 (26) 0.0273
SOFA coagulation ≥3, n (%) 134 (12.6) 15 (15.6) 0.5577
SOFA liver ≥3, n (%) 81 (7.6) 7 (7.3) 0.7845
Need for mechanical ventilation, n (%) 946 (89.2) 84 (87.5) 0.6661
Hypotension, n (%) 529 (49.9) 54 (56.3) 0.3263
Presumed source of infection    0.3336
 No clear source, n (%) 242 (22.8) 32 (33.3)  
 Catheter-related, n (%) 226 (21.3) 21 (21.9)  
 Respiratory, n (%) 230 (21.7) 14 (14.6)  
 Intra-abdominal, n (%) 122 (11.5) 12 (12.5)  
 Urinary, n (%) 43 (4.1) 4 (4.2)  
 Others, n (%) 67 (6.3) 6 (6.3)  
 Multiple sources, n (%) 130 (12.3) 7 (7.3)  
Source control    0.9820
 Not required, n (%) 590 (55.7) 54 (56.3)  
 Done, n (%) 429 (40.5) 38 (39.6)  
 Required not done, n (%) 41 (3.9) 4 (4.2)  
Delay of adequate treatment    <0.0001
 <24 h 586 (55.3) 22 (22.9)  
 >24 h and ≤120 h 335 (31.6) 59 (61.5)  
 >120 h 40 (3.8) 9 (9.4)  
 Never 99 (9.3) 6 (6.2)  
  1. SOFA Sequential Organ Failure Assessment